Fisher & Paykel Healthcare Limited
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.9M
Doctors Paid
6,798
Transactions
10,003
2024 Total
$1.4M
Payment Breakdown by Category
Research$5.0M (72.7%)
Consulting$795,823 (11.5%)
Food & Beverage$431,992 (6.3%)
Travel$251,884 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.0M | 104 | 72.7% |
| Consulting Fee | $795,823 | 59 | 11.5% |
| Food and Beverage | $431,992 | 9,468 | 6.3% |
| Travel and Lodging | $251,884 | 120 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $231,250 | 119 | 3.3% |
| Long term medical supply or device loan | $101,350 | 96 | 1.5% |
| Honoraria | $41,155 | 24 | 0.6% |
| Grant | $18,400 | 1 | 0.3% |
| Charitable Contribution | $10,000 | 1 | 0.1% |
| Entertainment | $1,092 | 3 | 0.0% |
| Gift | $240.00 | 8 | 0.0% |
Payments by Type
Research
$5.0M
104 transactions
General
$1.9M
9,899 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| myAirvo3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home | $1.7M | 0 | 5 |
| myAirvo3 for COPD Patients in the Home | $960,000 | 0 | 4 |
| myAirvo3 High Flow Nasal Therapy HFNT for COPD Patients in the Home | $880,000 | 0 | 4 |
| F&P 950 Respiratory Humidifier Human Factors Validation | $172,144 | 0 | 2 |
| Study of Humidified Air to Improve Mucociliary Clearance (MCC) in COPD | $121,001 | 0 | 5 |
| Effect of High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High Risk Patients with Systolic Heart Failure | $115,000 | 0 | 1 |
| High-flow nasal oxygen for advnaced endoscopy in hihg-risk patients | $99,500 | 0 | 3 |
| Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients | $68,674 | 0 | 3 |
| Physiological Changes with High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants | $60,000 | 0 | 1 |
| Optiflow THRIVE for delivery of oxgyen to patients during total intravenous anesthesia while undergoing radiology procedures. | $60,000 | 0 | 3 |
| THRIVE | $52,933 | 1 | 3 |
| Evaluation of the toffee full face mask | $51,675 | 0 | 2 |
| Clinical Trials | $48,373 | 3 | 9 |
| Human Factors Evaluation - OptiPAP Junior | $45,560 | 0 | 1 |
| High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients | $45,500 | 0 | 1 |
| Physiological Changes With High Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants | $43,454 | 0 | 1 |
| Physiological Changes With High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants | $39,510 | 0 | 1 |
| Physiological Changes With High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants, NCT03700606 | $35,000 | 1 | 1 |
| Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022 | $33,825 | 0 | 1 |
| Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures | $31,897 | 0 | 3 |
| Impact of humidification devices in patients with severe ARDS | $30,246 | 0 | 1 |
| Respiratory Function with NHF and CPAP. Bench studies only. | $22,846 | 0 | 1 |
| Effects of High Flow Nasal Cannula on Sputum Clearance in Acute Exacerbation of Chronic Obstructive Pulmonary Disease | $20,146 | 0 | 1 |
| Study of respiratory parameters during nasal high flow and nasal CPAP therapies | $20,000 | 1 | 1 |
| OptiPAP Jn Pilot Study protocol development | $20,000 | 0 | 1 |
| The Evaluation of a nasal pillows mask | $17,067 | 1 | 2 |
| myAIRVO | $16,840 | 1 | 1 |
| Consulting services for Research and Development | $16,800 | 0 | 1 |
| Research Grant | $16,382 | 1 | 1 |
| Tolerance and Acute effects of HFNC-O2 | $16,250 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| David Rapoport, M.d, M.D | Pulmonary Disease | New York, NY | $356,852 | $0 |
| Joseph Ojile, M.d, M.D | Pulmonary Disease | Saint Louis, MO | $268,477 | $0 |
| Neil Finer, M.d, M.D | Pediatrics | San Diego, CA | $264,899 | $0 |
| David Ostransky, D.o, D.O | Pulmonary Disease | Fort Worth, TX | $68,404 | $0 |
| Vladimir Nekhendzy, Md, MD | Anesthesiology | Stanford, CA | $64,393 | $0 |
| Gerard Criner, Md, MD | Pulmonary Disease | Philadelphia, PA | $56,729 | $0 |
| Dr. Eddy Gutierrez, Md, MD | Internal Medicine | Jacksonville, FL | $51,643 | $0 |
| Nicholas Hill, Md, MD | Critical Care Medicine | Boston, MA | $50,372 | $0 |
| Soraya Abbasi, Md, MD | Pediatrics | Philadelphia, PA | $36,382 | $0 |
| Dr. James Krainson, M.d.f.c.c.p, M.D.F.C.C.P | Pulmonary Disease | Miami, FL | $36,353 | $0 |
| Anup Katheria, M.d, M.D | Pediatrics | San Diego, CA | $35,734 | $0 |
| Amer Khan, Md, MD | Neurology with Special Qualifications in Child Neurology | Roseville, CA | $28,905 | $0 |
| Dr. Matthew Trump, Do, DO | Critical Care Medicine | West Des Moines, IA | $28,682 | $0 |
| Elizabeth C Behringer, Md, MD | Anesthesiology | Orange, CA | $24,118 | $0 |
| Juan Pulido, Md, MD | Pulmonary Disease | Jacksonville Beach, FL | $23,678 | $0 |
| Dr. Thomas O'brien, Md, MD | Critical Care Medicine | Kissimmee, FL | $23,524 | $0 |
| Dr. Asim Roy, M.d, M.D | Sleep Medicine | Dublin, OH | $19,393 | $0 |
| Dr. Eric Mccollum, M.d, M.D | Pediatrics | Baltimore, MD | $18,400 | $0 |
| Dr. Richard Polin | Neonatal-Perinatal Medicine | New York, NY | $14,367 | $0 |
| Alberto Marante, M.d, M.D | Pediatric Critical Care Medicine | Orlando, FL | $13,785 | $0 |
| Henry Wang, Md, Mph, Ms, MD, MPH, MS | Specialist | Columbus, OH | $13,516 | $0 |
| Dr. Jonathan Casey, M.d, M.D | Internal Medicine | Nashville, TN | $13,337 | $0 |
| Shahrokh Javaheri, Md, MD | Pulmonary Disease | Cincinnati, OH | $13,115 | $0 |
| Dr. Michael Allison, Md, MD | Critical Care Medicine | Baltimore, MD | $12,639 | $0 |
| Dr. Jarrod Mosier, M.d, M.D | Emergency Medicine | Tucson, AZ | $12,138 | $0 |
Ad
Top Products
- FISHER & PAYKEL HEALTHCARE $4.0M
- Airvo $1.1M
Associated Products (18)
- FISHER & PAYKEL HEALTHCARE $4.0M
- Airvo $1.1M
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment $646,433
- Optiflow Junior $181,300
- Optiflow THRIVE $52,933
- Fisher & Paykel Healthcare $33,825
- myAIRVO $33,090
- Optiflow $31,897
- MR850 $30,246
- OSA full face mask $25,919
- Airvo and Optiflow $20,146
- OSA Nasal Mask $19,509
- PT101US/Airvo 2 $18,499
- Vitera SP $18,095
- Optiflow Junior and Flexitrunk $16,382
- myAIRVO 2 Humidifier Home US $13,000
- SleepStyle $12,765
- SIP Seal $11,674
Payment Categories
- Food & Beverage $431,992
- Consulting $795,823
- Travel & Lodging $251,884
- Research $5.0M
About Fisher & Paykel Healthcare Limited
Fisher & Paykel Healthcare Limited has made $6.9M in payments to 6,798 healthcare providers, recorded across 10,003 transactions in the CMS Open Payments database. In 2024, the company paid $1.4M. The top product by payment volume is FISHER & PAYKEL HEALTHCARE ($4.0M).
Payments were distributed across 108 medical specialties. The top specialty by payment amount is Pulmonary Disease ($866,005 to 492 doctors).
Payment categories include: Food & Beverage ($431,992), Consulting ($795,823), Research ($5.0M), Travel & Lodging ($251,884).
Fisher & Paykel Healthcare Limited is associated with 18 products in the CMS Open Payments database, including FISHER & PAYKEL HEALTHCARE, Airvo, and Obstructive Sleep Apnea Device or Hospital Respiratory Equipment.